China Regulatory Express: Biosecurity Law, Export Controls And The Life Science Sector
Stiffer Fines For Violators
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
You may also be interested in...
In its most recent regulatory reforms, China is proposing to allow online sales of prescription drugs, a major step forward that could boost struggling retail pharmacies and further propel medicine e-commerce.
While many pharma firms in China choose to partner with US companies, Jiangsu Hengrui is relying on itself to go global. The Chinese pharma giant is betting on its newly established US subsidiary Luzsana in a major move to make its wide-ranging products more available, accessible and affordable to patients in the US and the rest of the world.
Home-grown Chinese mRNA COVID-19 vaccines are more effective than domestic inactivated virus-based shots, new trial results show.